Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

ClinicalTrials.gov ID: NCT03826550

Public ClinicalTrials.gov record NCT03826550. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Gel 3% (Encube Ethicals) Compared to Solaraze® (Diclofenac Sodium) Gel 3% (Fougera Pharmaceuticals Inc.) in the Treatment of Actinic Keratosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Therapeutic Equivalence of Diclofenac Sodium Gel 3% and Solaraze ®, in the treatment of Actinic Keratosis

Study identification

NCT ID
NCT03826550
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Encube Ethicals Pvt. Ltd.
Industry
Enrollment
655 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2018 (Actual)
Primary completion
Jun 30, 2018 (Actual)
Completion
Jul 3, 2018 (Actual)
Last update posted
Feb 1, 2019

2018

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Dermatology Trial Associates Bryant Arkansas 71011 —
West Coast Research San Ramon California 94582 —
Universal Medical and Research Center, LLC Coral Gables Florida 33134 —
Solutions Through Advanced Research, Inc. Jacksonville Florida 32256 —
Health Awareness, Inc. Jupiter Florida 33458 —
Multi-Speciality Research Associates, Inc. Lake City Florida 32055 —
FXM Research Miami Florida 33175 —
FXM Research Miramar Miramar Florida 33027 —
Ormond Medical Arts Pharmaceutical Research Center Ormond Beach Florida 32174 —
Moore Clinical Research Tampa Florida 33618 —
Forward Clinical Trials Tampa Florida 33624 —
Northwest Clinical Trials Boise Idaho 82704 —
DS Research New Albany Indiana 47150 —
DS Research Louisville Kentucky 40241 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
DTRL, Inc. Henderson Nevada 89052 —
Dermatology Consulting Services High Point North Carolina 27262 —
Sterling Research Group Cincinnati Ohio 45246 —
DermDox Centers for Dermatology Hazleton Pennsylvania 18201 —
PEAK Research, LLC Upper Saint Clair Pennsylvania 15241 —
Anderson Dermatology Anderson South Carolina 29621 —
Greenville Dermatology, LLC Greenville South Carolina 29607 —
Sirius Clinical Research, LLC Austin Texas 78759 —
Health Research of Hampton Roads, Inc. Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03826550, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2019 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03826550 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →